Italy has had the highest prevalence of hepatitis C virus (HCV) infection and mortality from HCV-related liver cancer in Europe. Although direct-acting antivirals (DAA) were initially restricted to persons with advanced fibrosis, their use has since been extended to all infected individuals; more than 244 000 persons have been treated to date. HCV liver-related mortality is expected to decline by 75% by 2030, achieving the World Health Organization target for mortality. However, Italy risks failing to meet the overall goal of eliminating HCV infection by 2030. In this light, €71.5 million have been allocated for screening initially specific target populations (persons who inject drugs, prison inmates, and the 1969-1989 birth cohort). Herein, we outline the challenges and recommendations for how to move Italy toward HCV elimination, including expanding screening programs in other populations, increasing awareness through strategic communication, sustaining DAA access, and tailoring care models to meet the needs of key populations.

Kondili Loreta, Craxì Lucia, Nava Felice, Babudieri Sergio, D'ambrosio Roberta, Marcellusi Andrea, et al. (2023). From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy. THE JOURNAL OF INFECTIOUS DISEASES, 228(Suppl 3), 211-220 [10.1093/infdis/jiad038].

From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy

Craxì Lucia
Co-primo
Writing – Original Draft Preparation
;
2023-01-01

Abstract

Italy has had the highest prevalence of hepatitis C virus (HCV) infection and mortality from HCV-related liver cancer in Europe. Although direct-acting antivirals (DAA) were initially restricted to persons with advanced fibrosis, their use has since been extended to all infected individuals; more than 244 000 persons have been treated to date. HCV liver-related mortality is expected to decline by 75% by 2030, achieving the World Health Organization target for mortality. However, Italy risks failing to meet the overall goal of eliminating HCV infection by 2030. In this light, €71.5 million have been allocated for screening initially specific target populations (persons who inject drugs, prison inmates, and the 1969-1989 birth cohort). Herein, we outline the challenges and recommendations for how to move Italy toward HCV elimination, including expanding screening programs in other populations, increasing awareness through strategic communication, sustaining DAA access, and tailoring care models to meet the needs of key populations.
2023
Kondili Loreta, Craxì Lucia, Nava Felice, Babudieri Sergio, D'ambrosio Roberta, Marcellusi Andrea, et al. (2023). From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy. THE JOURNAL OF INFECTIOUS DISEASES, 228(Suppl 3), 211-220 [10.1093/infdis/jiad038].
File in questo prodotto:
File Dimensione Formato  
From prioritization JID pubblicato.pdf

Solo gestori archvio

Descrizione: Articolo
Tipologia: Versione Editoriale
Dimensione 1.06 MB
Formato Adobe PDF
1.06 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/622934
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact